Erlotinib Tablets I.p. 100 Mg
Erlotinib Tablets I.p. 100 Mg

Erlotinib Tablets I.p. 100 Mg

Price 7000 INR/ Bottle

MOQ : 100 Bottles

Erlotinib Tablets I.p. 100 Mg Specification

  • Dosage Form
  • Tablet
  • Origin of Medicine
  • India
  • Life Span
  • Check expiry on pack
  • Indication
  • Non-small cell lung cancer, pancreatic cancer
  • Salt Composition
  • Erlotinib Hydrochloride
  • Pacakaging (Quantity Per Box)
  • 1*30 Tablet
  • Packaging Type
  • Box
  • Drug Type
  • Prescription medicine
  • Ingredients
  • Erlotinib
  • Physical Form
  • Tablet
  • Function
  • Anticancer, EGFR inhibitor
  • Recommended For
  • Cancer treatment (specifically non-small cell lung cancer)
  • Dosage
  • 100 mg
  • Dosage Guidelines
  • As directed by physician
  • Suitable For
  • Adults
  • Quantity
  • 30 tablets
  • Storage Instructions
  • Store below 30C, protect from moisture
  • Treatment Period
  • As prescribed
  • Brand Name
  • ERLOTERO-100
  • Country
  • India
  • Prescription
  • Required
  • Color
  • Film-coated tablet
  • Route
  • Oral Use Only
  • Box Label
  • Contains instructions
  • Manufactured By
  • Mylan
  • Language
  • Labelling in English, Hindi
  • Tablet Strength
  • 100 mg
 

Erlotinib Tablets I.p. 100 Mg Trade Information

  • Minimum Order Quantity
  • 100 Bottles
  • Supply Ability
  • 5000 Bottles Per Month
  • Delivery Time
  • 7 Days
 

Erlotinib Tablets I.p. 100 Mg About



Introducing ERLOTERO-100, the sought-after Erlotinib Tablets I.P. 100 mg by Mylan, perfect for those seeking a personalised approach in cancer care. This trending, prescription-only anticancer medicine is an ace EGFR inhibitor, designed specifically for adults battling non-small cell lung cancer and pancreatic cancer. Each lofty, film-coated tablet is available at a special price cut and comes with clear, bilingual labelling (English/Hindi). With each box containing 30 tablets, ERLOTERO-100 supports diverse treatment plans as prescribed by your physician. Exclusively made in India, it's a trusted and effective addition to therapy regimens.

Versatile Usage & Advanced Features of ERLOTERO-100

ERLOTERO-100 Erlotinib Tablets are administered orally and tailored for adults managing non-small cell lung cancer or pancreatic cancer. Their ace advantage lies in the film-coated design and measured 100 mg dosage, supporting precise personalisation as directed by a physician. Supplied in sealed boxes of 30 tablets with English and Hindi instructions, these trending tablets make cancer treatment accessible, reliable, and efficient. The shelf life and clear labelling further enhance the assurance for both patient and healthcare providers alike.


Swift Dispatch & Trusted Delivery Across Destinations

ERLOTERO-100 is available with stock ready for prompt dispatching, making sure patients get timely access to their medication. Freight options are flexible thanks to reliable FOB ports across major Indian hubs. Mylan upholds quality with all essential certifications, ensuring each batch meets stringent regulatory standards. With organised logistics and inventory, orders are efficiently processed and shipped, minimising delays and enhancing reliability for suppliers, traders, and healthcare institutions throughout India and abroad.


FAQ's of Erlotinib Tablets I.p. 100 Mg:


Q: How should ERLOTERO-100 Erlotinib Tablets be taken for best results?

A: ERLOTERO-100 tablets must be taken orally, strictly as directed by your physician. They should not be chewed or crushed, and are best taken on an empty stomach, at least one hour before or two hours after eating.

Q: What cancers are addressed by ERLOTERO-100 Erlotinib Tablets?

A: ERLOTERO-100 is mainly indicated for the treatment of non-small cell lung cancer and pancreatic cancer. Always consult your oncologist to determine suitability for your specific medical condition.

Q: When should I start treatment with ERLOTERO-100?

A: Initiation of treatment is determined by your treating specialist. Taking ERLOTERO-100 should begin only after a thorough discussion about your diagnosis and treatment plan as prescribed by your healthcare provider.

Q: Where is ERLOTERO-100 manufactured and can it be trusted?

A: ERLOTERO-100 is manufactured by Mylan in India, a renowned global pharmaceutical company. Each batch adheres to strict quality standards and is backed by the necessary certifications.

Q: What is the process for storing ERLOTERO-100 tablets safely?

A: Store ERLOTERO-100 tablets below 30C and keep them protected from moisture in their original box. Always check the expiry date on the pack and keep out of reach of children.

Q: How is ERLOTERO-100 beneficial for patients?

A: ERLOTERO-100 offers a personalised, targeted approach by inhibiting EGFR, a key factor in cancer cell proliferation, making it an effective solution for eligible patients, especially those with non-small cell lung or pancreatic cancer.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Oncology Medicine Category

Cabozantinib 40 Mg Tablet

Cabozantinib 40 Mg Tablet

Price 12000 INR / Bottle

Minimum Order Quantity : 100 Bottles

Origin of Medicine : India

Dosage Form : Tablet

Dosage Guidelines : For oral use only

Function : Other, Anticancer medication

Imutrex 10mg Tablet

Imutrex 10mg Tablet

Price 450 INR / Strip

Minimum Order Quantity : 100 Strips

Origin of Medicine : India

Dosage Form : Tablet

Dosage Guidelines : Follow doctors prescription

Function : Other, Immunosuppressant, antimetabolite

Dyronib Dasatinib Tablets

Dyronib Dasatinib Tablets

Price 19000 INR / Bottle

Minimum Order Quantity : 10 Bottles

Origin of Medicine : India

Dosage Form : Oral tablets

Dosage Guidelines : As prescribed by doctor

Function : Cancer Treatment

Apnat Apalutamide Tablets 60 mg

Apnat Apalutamide Tablets 60 mg

Minimum Order Quantity : 10 Pieces

Origin of Medicine : India

Dosage Form : Tablet

Dosage Guidelines : Follow physicians instructions

Function : Other, Anticancer therapy / Androgen receptor inhibitor



Back to top